Сингапур - Енглески - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - factor ix (human) - injection, powder, for solution - 1000 iu per 10ml vial - factor ix (human) 1000 iu per 10ml vial

Сингапур - Енглески - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - factor ix (human) - injection, powder, for solution - 1500 iu per 10ml vial - factor ix (human) 1500 iu per 10ml vial

Сингапур - Енглески - HSA (Health Sciences Authority)

grifols asia pacific pte. ltd. - factor ix (human) - injection, powder, for solution - 500 iu per 10ml vial - factor ix (human) 500 iu per 10ml vial

Канада - Енглески - Health Canada

baxter corporation - cyclophosphamide - tablet - 25mg - cyclophosphamide 25mg - antineoplastic agents

Канада - Енглески - Health Canada

baxter corporation - cyclophosphamide - tablet - 50mg - cyclophosphamide 50mg - antineoplastic agents

Канада - Енглески - Health Canada

baxter corporation - cyclophosphamide - powder for solution - 200mg - cyclophosphamide 200mg - antineoplastic agents

Канада - Енглески - Health Canada

baxter corporation - cyclophosphamide - powder for solution - 500mg - cyclophosphamide 500mg - antineoplastic agents

Канада - Енглески - Health Canada

baxter corporation - cyclophosphamide - powder for solution - 1000mg - cyclophosphamide 1000mg - antineoplastic agents

Канада - Енглески - Health Canada

baxter corporation - cyclophosphamide - powder for solution - 2000mg - cyclophosphamide 2000mg - antineoplastic agents

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

grifols usa, llc - coagulation factor ix human (unii: 6u90y1795t) (coagulation factor ix human - unii:6u90y1795t) - coagulation factor ix human 500 [iu] in 10 ml - alphanine sd is indicated for the prevention and control of bleeding in patients with factor ix deficiency due to hemophilia b. alphanine sd contains low, non-therapeutic levels of factors ii, vii, and x, and, therefore, is not indicated for the treatment of factor ii, vii or x deficiencies. this product is also not indicated for the reversal of coumarin anticoagulant-induced hemorrhage, nor in the treatment of hemophilia a patients with inhibitors to factor viii. none known.